exploring the combination of first-line avelumab/axitinib in hcc
Published 6 years ago • 353 plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
1:24
final results of avelumab and axitinib in rcc in the javelin renal 101 trial
-
2:31
javelin renal 101: combination approach for advanced rcc patients | laurence albiges
-
1:37
immunotherapy combinations improve survival in advanced renal cell carcinoma
-
1:38
dr. choueiri on avelumab plus axitinib in mrcc
-
2:27
combining avelumab and axitinib in advanced renal cell carcinoma (rcc)
-
9:30
study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
-
10:15
novel combinations in mrcc: axi/pembro vs axi/avelumab
-
0:44
real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
-
1:47
dr. choueiri discusses avelumab/axitinib data in rcc
-
9:23
javelin renal 101: avelumab plus axitinib improve pfs for advanced renal cell cancer
-
0:47
avelumab plus axitinib shows good efficacy for os and pfs in arcc patients
-
2:00
exploring the combination of epacadostat and pembrolizumab in urothelial carcinoma
-
1:06
dr. mcgregor on the utility of axitinib/avelumab in advanced rcc
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
3:41
tide-a: avelumab and intermittent axitinib in metastatic renal cell carcinoma
-
4:39
avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
-
2:32
avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients